Caribou Biosciences, Inc. (CRBU)

0.5004 +0.04 (+8.74%) USD  |  NASDAQ  |  Oct 12, 14:56
More

Caribou Biosciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for CRBU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
July 06, 2026 --
June 16, 2026 --
June 11, 2026 --
May 11, 2026 --
May 09, 2026 --
May 08, 2026 --
May 07, 2026 --
April 07, 2026 --
March 31, 2026 --
March 06, 2026 --
March 05, 2026 --
November 17, 2025 --
November 13, 2025 --
November 05, 2025 --
September 23, 2025 --
August 14, 2025 --
August 13, 2025 --
August 12, 2025 --
Date Value
June 27, 2025 --
June 11, 2025 --
May 09, 2025 --
May 08, 2025 --
April 28, 2025 --
April 25, 2025 --
March 19, 2025 --
March 12, 2025 --
March 11, 2025 --
November 15, 2024 --
November 07, 2024 --
September 03, 2024 --
August 15, 2024 --
August 07, 2024 --
May 10, 2024 --
May 08, 2024 --
April 18, 2024 --
April 10, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade